MARKET

GSK

GSK

GSK
NYSE

Real-time Quotes | Nasdaq Last Sale

37.07
-0.16
-0.43%
Closed 16:00 11/27 EST
OPEN
36.92
PREV CLOSE
37.23
HIGH
37.21
LOW
36.85
VOLUME
2.80M
TURNOVER
--
52 WEEK HIGH
48.25
52 WEEK LOW
31.43
MARKET CAP
93.00B
P/E (TTM)
11.36
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Pharma Stock Roundup: AZN COVID-19 Vaccine Interim Data, PFE Emergency Use Appeal
AstraZeneca (AZN) COVID-19 vaccine candidate proves effective in late-stage study. Pfizer (PFE) seeks Emergency use for its COVID-19 vaccine candidate.
Zacks · 2d ago
The Zacks Analyst Blog Highlights: UnitedHealth, CRM, GSK, Square and American Electric Power
The Zacks Analyst Blog Highlights: UnitedHealth, CRM, GSK, Square and American Electric Power
Zacks · 5d ago
Coronavirus update: HHS puts vaccine distribution in states' power; Wall Street analysts project lifelong vaccine protection
With three vaccine candidates out with a first look at efficacy data, Wall Street is more optimistic about the light at the end of the pandemic tunnel.
Yahoo Finance · 5d ago
Glaxo's (GSK) RSV Vaccine for Pregnant Women Enters Phase III
Glaxo (GSK) is developing vaccine against respiratory syncytial virus for pediatric patients, pregnant women and older adults. The candidates hold significant potential.
Zacks · 5d ago
Coronavirus update: FDA OKs Regeneron antibody EUA; AstraZeneca shows positive vaccine results
U.S. cases surpass 12 million as positive vaccine and antibody treatment news provide hope.
Yahoo Finance · 6d ago
Vaccine access and distribution a big topic at G20
At this weekend's summit in Riyadh, G20 leaders pledged to ensure fair distribution of COVID-19 vaccines, drugs and tests around the world so that poorer countries were not left out
Seekingalpha · 11/22 14:12
Top Stock Reports for UnitedHealth, salesforce & GlaxoSmithKline
Top Stock Reports for UnitedHealth, salesforce & GlaxoSmithKline
Zacks · 11/20 20:33
Trump administration ready to distribute Covid vaccines if approved, 'Warp Speed' advisor says
"As soon as the EUA is approved, within 24 hours, the vaccines will be in the immunization sites and people will be immunized," Dr. Moncef Slaoui told CNBC.
CNBC.com · 11/20 16:45
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GSK. Analyze the recent business situations of GSK through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average GSK stock price target is 48.17 with a high estimate of 52.00 and a low estimate of 41.50.
EPS
Institutional Holdings
Institutions: 1.16K
Institutional Holdings: 314.11M
% Owned: 12.52%
Shares Outstanding: 2.51B
TypeInstitutionsShares
Increased
235
11.90M
New
144
-294.08K
Decreased
329
19.23M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.12%
Pharmaceuticals & Medical Research
+1.72%
Key Executives
Non-Executive Chairman/Independent Director
Jonathan Symonds
Chief Executive Officer/Executive Director
Emma Walmsley
Chief Financial Officer/Executive Director
Iain Mackay
Corporate Executive
Roger Connor
Corporate Executive
Brian McNamara
Corporate Executive
Luke Miels
Corporate Executive
Abbas Hussain
Corporate Executive
Regis Simard
Corporate Executive
Phil Thomson
Corporate Executive
Deborah Waterhouse
Senior Vice President/General Counsel
James Ford
Senior Vice President/Director of Human Resources
Diana Conrad
Senior Vice President
Nick Hirons
Senior Vice President
Sally Jackson
Chief Technology Officer
Karenann Terrell
Chief Scientific Officer/Executive Director
Hal Barron
Other
David Redfern
Non-Executive Independent Director
Manvinder Banga
Secretary
Victoria Whyte
Non-Executive Director
Charles Bancroft
Non-Executive Independent Director
Marvinder Banga
Non-Executive Independent Director
Vivienne Cox
Non-Executive Independent Director
Lynn Elsenhans
Non-Executive Independent Director
Laurie Glimcher
Non-Executive Independent Director
Jesse Goodman
Non-Executive Independent Director
Judy Lewent
Non-Executive Independent Director
Urs Rohner
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.488438
11/12/2020
07/29/2020
Dividend USD 0.4854219
08/13/2020
04/29/2020
Dividend USD 0.4664139
05/14/2020
02/05/2020
Dividend USD 0.5594826
02/20/2020
--
Dividend USD 0.4923352
11/14/2019
--
Dividend USD 0.4583283
08/08/2019
--
Dividend USD 0.465536
05/16/2019
02/07/2019
Dividend USD 0.594243
02/21/2019
11/01/2018
Dividend USD 0.479
11/15/2018
07/25/2018
Dividend USD 0.491
08/09/2018
04/26/2018
Dividend USD 0.525
05/10/2018
02/07/2018
Dividend USD 0.647
02/22/2018
10/25/2017
Dividend USD 0.509
11/09/2017
07/26/2017
Dividend USD 0.496
08/09/2017
07/11/2017
Dividend USD 0.485
05/10/2017
04/11/2017
Dividend USD 0.566
02/22/2017
01/10/2017
Dividend USD 0.457
11/02/2016
10/11/2016
Dividend USD 0.462
08/10/2016
07/12/2016
Dividend USD 0.495
05/11/2016
04/12/2016
Dividend USD 1.233
02/17/2016
01/12/2016
Dividend USD 0.544
11/10/2015
09/29/2015
Dividend USD 0.572
08/12/2015
07/07/2015
Dividend USD 0.581
05/13/2015
02/04/2015
Dividend USD 0.695
02/18/2015
10/22/2014
Dividend USD 0.613
11/05/2014
07/23/2014
Dividend USD 0.648
08/06/2014
04/30/2014
Dividend USD 0.64
05/14/2014
02/05/2014
Dividend USD 0.75
02/19/2014
10/23/2013
Dividend USD 0.616
11/13/2013
07/24/2013
Dividend USD 0.553
08/07/2013
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About GSK
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of GlaxoSmithKline plc (ADR) stock information, including NYSE:GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.